Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies
11 Dec 2021
Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
Latest in advanced endometrial cancer
Oncology nursing in the global south during COVID-19
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Post-HSCT management of ALL - Adult ALL perspective
Latest in diagnostics in EGFR mutated NSCLC
The Lancet Commission on women and cancer
Cancer drug policy and access in LMICs
Faculty development workshop at AORTIC
Paediatric ALL perspective
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)